These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 38716106
1. Structural insights into novel therapeutic deep eutectic systems with capric acid using 1D, 2D NMR and DSC techniques with superior gut permeability. Alkhawaja B, Al-Akayleh F, Nasereddin J, Kamran M, Woodman T, Al-Rubaye Z, Qinna N, Al-Remawi M, Olaimat AR. RSC Adv; 2024 May 02; 14(21):14793-14806. PubMed ID: 38716106 [Abstract] [Full Text] [Related]
2. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems. Aroso IM, Silva JC, Mano F, Ferreira AS, Dionísio M, Sá-Nogueira I, Barreiros S, Reis RL, Paiva A, Duarte AR. Eur J Pharm Biopharm; 2016 Jan 02; 98():57-66. PubMed ID: 26586342 [Abstract] [Full Text] [Related]
3. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies. Duarte AR, Ferreira AS, Barreiros S, Cabrita E, Reis RL, Paiva A. Eur J Pharm Biopharm; 2017 May 02; 114():296-304. PubMed ID: 28189620 [Abstract] [Full Text] [Related]
4. Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery. Javed S, Mangla B, Sultan MH, Almoshari Y, Sivadasan D, Alqahtani SS, Madkhali OA, Ahsan W. Heliyon; 2024 May 15; 10(9):e29783. PubMed ID: 38694051 [Abstract] [Full Text] [Related]
5. A Novel Eutectic-Based Transdermal Delivery System for Risperidone. Al-Akayleh F, Adwan S, Khanfar M, Idkaidek N, Al-Remawi M. AAPS PharmSciTech; 2020 Nov 22; 22(1):4. PubMed ID: 33221990 [Abstract] [Full Text] [Related]
6. Levofloxacin-Fatty Acid Systems: Dual Enhancement Through Deep Eutectic Formation and Solubilization for Pharmaceutical Potential and Antibacterial Activity. Alkhawaja B, Al-Akayleh F, Nasereddin J, Malek SA, Alkhawaja N, Kamran M, Al-Rubaye Z, Smairat M, Al-Remawi M, Aburayyan WS. AAPS PharmSciTech; 2023 Nov 29; 24(8):244. PubMed ID: 38030950 [Abstract] [Full Text] [Related]
7. Properties of Therapeutic Deep Eutectic Solvents of l-Arginine and Ethambutol for Tuberculosis Treatment. Santos F, P S Leitão MI, C Duarte AR. Molecules; 2018 Dec 24; 24(1):. PubMed ID: 30586896 [Abstract] [Full Text] [Related]
9. Solids Turn into Liquids-Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility. Sarraguça MC, Ribeiro PRS, Nunes C, Seabra CL. Pharmaceuticals (Basel); 2022 Feb 23; 15(3):. PubMed ID: 35337077 [Abstract] [Full Text] [Related]
10. Deep Eutectic Solvents: An Eco-friendly Design for Drug Engineering. Oyoun F, Toncheva A, Henríquez LC, Grougnet R, Laoutid F, Mignet N, Alhareth K, Corvis Y. ChemSusChem; 2023 Oct 20; 16(20):e202300669. PubMed ID: 37463123 [Abstract] [Full Text] [Related]
11. Eutectic-based liposome as a potential delivery system of paeonol. Wu J, Yang S, Yin T, Wang X. RSC Adv; 2021 Dec 06; 11(62):39343-39348. PubMed ID: 35492495 [Abstract] [Full Text] [Related]
12. Formulation of Ascorbic Acid and Betaine-based Therapeutic Deep Eutectic System for Enhanced Transdermal Delivery of Ascorbic Acid. Song JE, Jun SH, Ryoo JY, Kang NG. Pharmaceutics; 2024 May 20; 16(5):. PubMed ID: 38794349 [Abstract] [Full Text] [Related]
13. Optimal Design of THEDES Based on Perillyl Alcohol and Ibuprofen. Silva E, Oliveira F, Silva JM, Matias A, Reis RL, Duarte ARC. Pharmaceutics; 2020 Nov 20; 12(11):. PubMed ID: 33233659 [Abstract] [Full Text] [Related]
14. Therapeutic deep eutectic solvents: A comprehensive review of their thermodynamics, microstructure and drug delivery applications. Abdelquader MM, Li S, Andrews GP, Jones DS. Eur J Pharm Biopharm; 2023 May 20; 186():85-104. PubMed ID: 36907368 [Abstract] [Full Text] [Related]
15. Overview and thermodynamic modelling of deep eutectic solvents as co-solvents to enhance drug solubilities in water. Zarei A, Haghbakhsh R, Raeissi S. Eur J Pharm Biopharm; 2023 Dec 20; 193():1-15. PubMed ID: 37838144 [Abstract] [Full Text] [Related]
16. Amorphization of Ethenzamide and Ethenzamide Cocrystals-A Case Study of Single and Binary Systems Forming Low-Melting Eutectic Phases Loaded on/in Silica Gel. Trzeciak K, Wielgus E, Kaźmierski S, Pawlak T, Potrzebowski MJ. Pharmaceutics; 2023 Apr 13; 15(4):. PubMed ID: 37111719 [Abstract] [Full Text] [Related]
17. Selective detection of active pharmaceutical ingredients in tablet formulations using solid-state NMR spectroscopy. Hong YL, Manjunatha Reddy GN, Nishiyama Y. Solid State Nucl Magn Reson; 2020 Apr 13; 106():101651. PubMed ID: 32058901 [Abstract] [Full Text] [Related]
18. Understanding Molecular Interactions in Rafoxanide-Povidone Amorphous Solid Dispersions from Ultrafast Magic Angle Spinning NMR. Li M, Meng F, Tsutsumi Y, Amoureux JP, Xu W, Lu X, Zhang F, Su Y. Mol Pharm; 2020 Jun 01; 17(6):2196-2207. PubMed ID: 32392076 [Abstract] [Full Text] [Related]
19. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance. Fule R, Dhamecha D, Maniruzzaman M, Khale A, Amin P. Int J Pharm; 2015 Dec 30; 496(1):137-56. PubMed ID: 26471056 [Abstract] [Full Text] [Related]
20. Antibacterial and Antioxidant Study of New Pharmaceutical Formulation of Didecyldimethylammonium Bromide Via Pharmaceutical Deep Eutectic Solvents (PDESs) Principle. Qader IB, Ganjo AR, Ahmad HO, Qader HA, Hamadameen HA. AAPS PharmSciTech; 2024 Jan 24; 25(1):25. PubMed ID: 38267795 [Abstract] [Full Text] [Related] Page: [Next] [New Search]